Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Worldwide, Randomized, Double Blind, Placebo-Controlled, Parallel Group Clinical Trial to Evaluate the Safety and Efficacy of Rizatriptan for the Acute Treatment of Migraine in Children and Adolescents

NCT01001234 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT01001234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01001234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Worldwide, Randomized, Double Blind, Placebo-Controlled, Parallel Group Clinical Trial to Evaluate the Safety and Efficacy of Rizatriptan for the Acute Treatment of Migraine in Children and Adolescents
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2009
Completion date
April 21, 2011
Enrollment
1,382 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

migraine, acute